Dysplain Syndrome: Symptoms, Causes and Treatment
The syndrome of the pioneering function is a group of blood diseases, as the basic imbalance is in the bone marrow, that is, the bone marrow responsible for the production of blood. These diseases are characterized by a quantitative and functional and functional defect in the process of different blood cell production. In a portion of patients, the defect can develop into leukemia, and this syndrome is more common among men in the seventh decade of life, although cases have recently been diagnosed among young people. Patients generally complain about weakness and fatigue that causes anemia of regular infections, bleeding, sometimes weight loss, sweat and other unlimited complaints. Varieties of piot outlets are usually classified as the syndrome in 5 forms, which are as follows: 1. Refractive anemia in this kind is a defect in the production of blood in the bone marrow with a percentage of aromatic cells less than 5%. 2. Refactive anemia with Ringard Sideroblasts – Rars) or known as the Idipatic Sideroblastic Ania – ISA This type of anemia is similar to free anemia, but it also contains an extra defect to use iron to produce blood cells. The imbalance is characterized by the formation of blue rings in the red blood cells in the bone marrow as a special dye is used, from here the name of this kind of anemia is derived. 3.. Refactive anemia with Excel or Blasts – Raib). Its benefits are similar to the characteristics of the above anemia mentioned above, but the amount of orthopedic cells in the bone marrow is 5% – 20%, and this disease is a more advanced stage than the syndrome. 4. The chronic myelomonocytic leukemia has its benefits similar to the features of free anemia, in addition to a surplus of aromatic cells and the large number of white cells of monocetes, and the controversy between scientists continues for years for considering this syndrome as part of the syndrome of disintegration syndrome or not. 5. The free anemia with an excess of the transformers – raeb – t) This disorder is characterized by a relatively high aromatic cells by 20% – 30%, and during the past two years this group has been ignored and many believe that this kind of anemia is not just the exposure in itself. Generally, in addition to the diagnosis based on bone marrow examination, is a chromosome examination that helps the diagnosis, especially to determine the degree of the severity of the disease and its uniform and future expectation. Symptoms of Pap Dysplasia syndrome range in the clinical symptoms of this syndrome of the easy degrees that are diagnosed by chance and even advanced degrees of the disease. In easy degrees, there is a deviation that sometimes deals with a laboratory examination without any complications and without treatment. In difficult degrees, a short -term disease is accompanied by difficult complications that include infections and bleeding with the possibility of death due to complications or due to acute blood leukemia. Causes and the risk of risk of porridge dysfunction syndrome have been observed over the past two decades the increasing appearance of the secondary image from the pillar of the pioneering function. The conversation in general is about young patients who were injured many years earlier with another malignant disease, such as: Hodgkin disease, lymph nodes, breast cancer and cancer, and then successfully treated with chemotherapy or radiotherapy, after a few years, a portion of patients succeeded from cancer with the syndrome. The diagnosis of myelouts defex syndrome was diagnosed with anemia at the majority of people with this syndrome, as half of patients with this syndrome have anemia, in addition to a decrease in the number of white blood cells and a decrease in the number of blood codes. The final diagnosis of the disease is determined, depending on the bone marrow examination in which a defect appears in the production of different blood cells, and young cells called aromatic cells can also be observed, the percentage of oral cells help with the diagnosis and to graduate the syndrome as it increases the differential diagnosis of blood white, in the natural bone marrow, the ratio of aromatic cells is not more than 5%. After diagnosis, it is important to evaluate the action of the disease, where the degree of the disease is classified into a high or low degree based on different criteria, such as :: defects in red blood cells only and not in other types of blood, and the absence of chromosome disorders in the bone marrow, all these criteria indicate that the syndrome places the patient in the patient, as the Syndrome a dangerous degree high. Treatment of the PAP Dysplasia Syndrome, the treatment recommended to be adopted to treat a variety of metropolitan syndrome and is suitable for the patient, some of the elderly therapists may possibly like this day. The search for a defined and specific treatment can be used as the best treatment, for this reason it is followed by the recommendation of moderate treatment for patients with the degree of low risk, here is the available treatments: treatment is follow -up and monitoring. The patient’s suppository in blood doses if necessary. Anti -Antibiotic therapy if necessary. Transfer the lips to the patient when it bleeds. A portion of patients have been given over the past few years, a hormone responsible for the production of red blood cells that sometimes increase the level of red blood cells and compensate the need for transfusion. Treatment such as bone marrow transplanting for youth is suggested because it has the ability to withstand more serious treatments, if a suitable donor is not available, or that this type of treatment is not originally recommended by acute chemotherapy, similar to the treatment of acute leukemia. As far as adults are concerned, they are still considered a challenge in terms of the type of treatment suitable for them, while the spectrum of the proposed treatments is expanded to varying of the mere follow-up and supportive treatment, such as: blood transfusion, anthropogenic injections, light chemotherapy and acute chemotherapy in the format of acute blood label and ends with experimental treatments. The treatment of anemia of this type associated with the treatment of the initial disease, if the treatment is successful, improves the anemia associated with the disease, and several research has recently shown that these patients also respond to the treatment of anthropogenic injections.